Dáil Éireann Debate, Wednesday - 18 April 2012
1232 Deputy Paschal Donohoe asked the Minister for Health if there are any plans in the near future to have the drug Pradaxa added to the list of drugs available on the medical card scheme and the drugs payment scheme; and if he will make a statement on the matter. [18055/12]
View answerPradaxa is available under the GMS Scheme, the Drug Payment Scheme and other community drugs schemes for the prevention of blood clots in adult patients who have undergone elective hip replacement surgery or elective knee replacement surgery.
The HSE is assessing the availability of resources to provide for the long term treatment with Pradaxa for the prevention of stroke in patients with atrial fibrillation. This is a complicated process with long term implications. The HSE wrote to all GMS doctors and community pharmacy contractors in November 2011 to clarify the position in relation to Pradaxa. The HSE will continue to update healthcare professionals in relation to the matter.
The HSE does not intend to disturb established therapeutic regimens for patients whose treatment with Pradaxa for the prevention of stroke was initiated prior to the clarification.
